You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

erlotinib

Showing 1 - 25 of 325
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liver Cancer Trial in Houston (Bevacizumab, Erlotinib)

Completed
Has Results
  • Liver Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 3, 2022

EGFR Positive NSCLC Trial in Goyang-Si (Erlotinib plus Bevacizumab, Erlotinib)

Active, not recruiting
  • EGFR Positive Non-small Cell Lung Cancer
  • Erlotinib plus Bevacizumab
  • Erlotinib
  • Goyang-Si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Solid Tumors, Advanced Solid Tumors, Metastatic Cancer Trial in Korea, Republic of (bevacizumab, erlotinib)

Recruiting
  • Solid Tumors
  • +2 more
  • Daejeon, Chungcheongnam-do, Korea, Republic of
  • +9 more
Jun 6, 2023

Lung Cancer Trial in Houston (DOTAP:Chol-TUSC2, Erlotinib, Dexamethasone)

Terminated
  • Lung Cancer
  • Houston, Texas
    UT MD Anderson Cancer Center
Feb 11, 2022

NSCLC Stage II, NSCLC, Stage IIIA Trial in Goyang-si (Erlotinib)

Active, not recruiting
  • NSCLC Stage II
  • NSCLC, Stage IIIA
  • Erlotinib
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Non Small Cell Lung Cancer Trial in United States (SNDX-275, erlotinib)

Completed
  • Non Small Cell Lung Cancer
  • Duarte, California
  • +11 more
Apr 25, 2022

NSCLC Trial in New Haven, Farmington (KD019, Erlotinib)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • New Haven, Connecticut
  • +1 more
May 9, 2022

Lung Cancer, Nonsmall Cell Trial in Lebanon (IRX4204, erlotinib)

Suspended
  • Lung Cancer, Nonsmall Cell
  • Lebanon, New Hampshire
    Geisel School of Medicine at Dartmouth
Mar 29, 2022

Biliary Tract Cancer Trial in Seoul (Pemetrexed 500 MG, Erlotinib)

Recruiting
  • Biliary Tract Cancer
  • Pemetrexed 500 MG
  • Erlotinib
  • Seoul, Korea, Republic of
  • +1 more
Jun 13, 2022

NSCLC Trial in United States (bevacizumab, Erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Galloway, New Jersey
  • +6 more
Jun 17, 2022

Cirrhosis, Hepatocellular Carcinoma Trial in United States (Erlotinib, Erlotinib Hydrochloride, Laboratory Biomarker Analysis)

Active, not recruiting
Has Results
  • Cirrhosis
  • Hepatocellular Carcinoma
  • Erlotinib
  • +3 more
  • Jacksonville, Florida
  • +5 more
Feb 24, 2022

Head Neck Cancer Trial in Houston (drug, other, behavioral)

Active, not recruiting
  • Head and Neck Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 31, 2022

NSCLC Trial in United States (erlotinib, bemcentinib)

Completed
  • Non-Small Cell Lung Cancer
  • Los Angeles, California
  • +9 more
Aug 16, 2022

NSCLC Trial in Worldwide (Erlotinib, Docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Wien, Austria
  • +31 more
Aug 23, 2022

Non-Small-Cell Lung Carcinoma, Carcinoma, Non-Small Cell Lung Trial in United States (Entinostat, Placebo, Erlotinib)

Completed
Has Results
  • Non-Small-Cell Lung Carcinoma
  • Carcinoma, Non-Small Cell Lung
  • Tucson, Arizona
  • +29 more
Aug 18, 2022

Cancer Medicines in Metastatic Non-small Cell Lung Cancer in

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Oslo, Norway
    Pfizer Norway
Apr 17, 2023

Unresectable Adenocarcinoma of the Esophagus, Metastatic Adenocarcinoma of the Esophagus, Unresectable Adenocarcinoma of Gastric

Completed
Has Results
  • Unresectable Adenocarcinoma of the Esophagus
  • +3 more
  • Los Angeles, California
  • +1 more
Sep 3, 2021

Esophageal Cancer Trial in United States (Erlotinib, Bevacizumab, Paclitaxel)

Completed
Has Results
  • Esophageal Cancer
  • Erlotinib
  • +6 more
  • Fort Myers, Florida
  • +8 more
Feb 18, 2022

NSCLC Trial in Seoul (CS-7017, Erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Seoul, Songpa-Gu, Korea, Republic of
    Asan Medical Center
Apr 16, 2021

Lung Cancer Trial in Worldwide (Erlotinib, Bevacizumab)

Completed
Has Results
  • Lung Cancer
  • Caen, France
  • +47 more
Aug 23, 2022

Lung Cancer Trial in New Haven, Houston (Erlotinib, AZD6244, MK-2206)

Completed
Has Results
  • Lung Cancer
  • Erlotinib
  • +3 more
  • New Haven, Connecticut
  • +1 more
Dec 14, 2021

Pancreatic Cancer Trial in La Jolla (Gemcitabine, Erlotinib)

Completed
  • Pancreatic Cancer
  • La Jolla, California
    UCSD Moores Cancer Center
Mar 1, 2021

Cancer Trial in Oslo, Trondheim (Erlotinib, Radiation)

Terminated
  • Cancer
  • Erlotinib
  • Radiation
  • Oslo, International/Other, Norway
  • +1 more
Mar 25, 2021

Lung Cancer, Non Small Cell Lung Cancer (NSCLC), Breast Cancer Trial in Sarasota, Oklahoma City, Nashville (entinostat,

Completed
  • Lung Cancer
  • +3 more
  • Sarasota, Florida
  • +2 more
Nov 11, 2021

Non-small Cell Lung Carcinoma Trial (Pembrolizumab, Paclitaxel, Carboplatin)

Completed
Has Results
  • Non-small Cell Lung Carcinoma
  • Pembrolizumab
  • +7 more
  • (no location specified)
Oct 13, 2022